What is Abeona Therapeutics Inc?
, a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 165.31M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 555,428 shares $296k | 115,000 shares $34k |
| 3-6months | 14259,481 shares $1.6M | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |